Bayer Receives Fast Track Designation from FDA for asundexian to Prevent Thrombosis in Patients with Atrial Fibrillation

Bayer Receives Fast Track Designation from FDA for asundexian to Prevent Thrombosis in Patients with Atrial Fibrillation

May 16, 2023: Bayer announced that the FDA has granted fast-track status to asundexian, an oral factor 11a inhibitor in clinical development as a potential treatment for stroke and systemic embolism in patients with atrial fibrillation.

Drug candidates that receive fast-track designation will be able to communicate more frequently with...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
This website is automatically translated using Google Translate.